维普期刊资源整合服务平台（V6.5）

69篇 您的检索式：作者名="Otterson GA"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of pl6INK4 protein induction by 5--aza 2' deoxy-- cytidine显示文摘	Otterson GA Khleif SN Chen W	1995	Oncogene1995，11，：	1
2	Protein expression and functional analysis of the FHIT genhuman tumor cells显示文摘	Otterson GA Xiao GH Geradts J	1998	J Natl Cancer Inst1998，90，6：	1
3	A phase Ⅱ study of oxaliplatin and paclitaxel in patients with advanced non-small cell lung cancer显示文摘	Winegarden JD Mauer AM Otterson GA	2004	Ann Oncol2004，15，：	1
4	A phase Ⅱ study of oxaliplatin and paclitaxel in patients with advanced non - small- cell lung cancer显示文摘	Winegarden JD Mauer AM Otterson GA etal	2004	Ann Oncol2004，15，6：	1
5	Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein 显示文摘	Kim YW Otterson GA Kratzke RA	1994	Mol Cell Biol1994，14，11：	1
6	Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignancies显示文摘	Nadella P Shapiro C Otterson GA	2002	J Clin Oncol2002，20，11：	1
7	Altered p16INK4 and RB1 expressions are associated with poor prognosis in patients with nonsmall cell lung cancer显示文摘	Zhao W Huang CC Otterson GA	2012	J Oncol2012，2012，95：	1
8	Immunohistochemical analyses of the p16INK4cyclin-dependent Kinase inhibitor in malignant mesothelioma显示文摘	Kratzke RA Otterson GA Lincoln CE	1995	J Natl CancerInst1995，58，：	1
9	Benefits and limitations of antiangiogenic agents in patients with non-small cell lung cancer显示文摘	Bertino EM Otterson GA	2010	Lung Cancer2010，70，3：	1
10	A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer 显示文摘	Rudin CM Otterson GA Mauer MA	2002	Ann Oneol2002，13，4：	1
11	Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wild type Rb显示文摘	Otterson GA Kratzke RA: Coxon A	1994	Oncogene1994，9，：	1
12	RB protein status and clinical correlation from 171 cell lines representing lung cancer,extrapulmonary small cell carcinoma,and mesothelioma显示文摘	Coxon A Otterson GA	1994	Oncogene1994，9，9：	1
13	Phase Ⅱ evaluation of docetaxel-modulated capecitabine in previously treated patients with non-small cell lung cancer显示文摘	Kindwall-Keller T Otterson GA Young D	2005	Clin Cancer Res2005，11，5：	1
14	A phase Ⅱ study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cance显示文摘	Winegardenl JD Mauerl AM Otterson GA	2004	Annals of Oncology2004，15，：	1
15	Protein expression and functional analysis of the FHIT gene in human tumor cells显示文摘	Otterson GA Xiao GH Geradts J		0，，：	1
16	A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer 显示文摘	Rudin CM Otterson GA Mauer AM	2002	Ann Oncol2002，13，4：	1
17	CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16/INK4 protein induction by 5-Aza-2 - doexycytidine显示文摘	Otterson GA Khleif SN Chen W	1995	Oncogene1995，11，：	1
18	Protein expression and functional analysis of the FHIT gene in human tumor cells显示文摘	Otterson GA Xiao GH Geradts J	1998	J Natl Cancer Inst1998，90，：	1
19	A phase n study of oxaliplatin and paclitaxel with advanced non -small cell lung cancer 显示文摘	Winegarden TD Mauer AM Otterson GA	2004	Ann Oncol2004，15，6：	1
20	A phase Ⅰ /Ⅱ trial of genasense and paclitaxel in chemorefractory small cell lung cancer 显示文摘	Rudin C Otterson GA George CM	2001	Proc Am Clin Oncol2001，20，3：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示